Development of MpM is associated with the loss of tumour suppressor genes, in particular, NF211,13–15 and CDKN2A11,17 both of which were deleted/silenced in the primary cells used in our experiments, and there is evidence linking the loss of these to translational dysregulation in a way that is consistent with our observations. This evidence concerns the gene MTLN and neoplasm.